Transdermal Drug Delivery
Transdermal drug delivery (TDDS) has transformed medicine, offering non-invasive, controlled-release drug administration with enhanced patient compliance. Since the approval of the first transdermal patch—scopolamine (Transderm Scop®) in 1979, TDDS has evolved beyond traditional patches to include nanotechnology-driven formulations and smart polymer-based systems.
At Dr. David’s Lab, we develop TDDS platforms that enhance drug absorption, stability, and targeted therapeutic action. By leveraging nanoparticles, lipid carriers, and biomaterials, our research aims to overcome skin barrier challenges, optimize drug release, and minimize systemic side effects, driving innovation in precision-driven transdermal therapeutics.
In addition to TDDS, our lab focuses on nanoemulsions, lipid-based systems, and polymeric gels for enhanced topical drug delivery. We optimize solubility, stability, and skin penetration to develop effective treatments for skincare, wound healing, and inflammation. By integrating bioactive compounds and nanotechnology, we improve drug retention, controlled release, and therapeutic outcomes.
Research
Transdermal & Topical Drug Delivery
Transdermal drug delivery (TDDS) has transformed medicine, offering non-invasive, controlled-release drug administration with enhanced patient compliance. Since the approval of the first transdermal patch—scopolamine (Transderm Scop®) in 1979—TDDS has evolved beyond traditional patches to include nanotechnology-driven formulations and smart polymer-based systems.
At Dr. David’s Lab, we develop TDDS platforms that enhance drug absorption, stability, and targeted therapeutic action. By leveraging nanoparticles, lipid carriers, and biomaterials, our research aims to overcome skin barrier challenges, optimize drug release, and minimize systemic side effects, driving innovation in precision-driven transdermal therapeutics.
In addition to TDDS, our lab focuses on nanoemulsions, lipid-based systems, and polymeric gels for enhanced topical drug delivery. We optimize solubility, stability, and skin penetration to develop effective treatments for skincare, wound healing, and inflammation. By integrating bioactive compounds and nanotechnology, we improve drug retention, controlled release, and therapeutic outcomes.
Research
Our research integrates nanotechnology, biomaterials, and natural product-based drug delivery to advance transdermal and topical therapeutic solutions with enhanced drug absorption, stability, and targeted action.
Key Focus Areas:
-
Nanoparticle-based drug carriers for controlled transdermal and topical delivery.
-
Natural product-based formulations for enhanced bioactivity and skin health.
-
Polymeric gels, nanoemulsions, and lipid-based delivery systems for improved drug solubility and penetration.
-
Bioactive compounds and antioxidants for skincare, wound healing, and dermatological applications.
By integrating formulation science and natural bioactives, we bridge the gap between traditional medicine and modern drug delivery, creating effective, sustainable, and patient-friendly treatments.
Collaboration Opportunities
We are actively seeking collaborations with:
-
Academic researchers exploring novel drug delivery technologies.
-
Pharmaceutical and biotech companies interested in innovative transdermal and topical formulations.
-
Clinicians and healthcare professionals to translate lab-based discoveries into real-world applications.
-
Funding agencies and industry partners to support the development and commercialization of advanced drug delivery platforms.
If you are interested in collaborating on transdermal or topical drug delivery research, contact us at snakkada@uwyo.edu to explore partnership opportunities.